Candriam S.C.A. Has $19.28 Million Stock Position in Chemed Corporation $CHE

Candriam S.C.A. reduced its position in Chemed Corporation (NYSE:CHE) by 22.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 43,056 shares of the company’s stock after selling 12,553 shares during the period. Candriam S.C.A. owned about 0.30% of Chemed worth $19,278,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Smartleaf Asset Management LLC raised its stake in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the period. Creekmur Asset Management LLC purchased a new position in shares of Chemed during the second quarter valued at $28,000. First Horizon Corp purchased a new position in shares of Chemed during the third quarter valued at $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Chemed during the third quarter valued at $45,000. Finally, Parkside Financial Bank & Trust lifted its stake in Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after acquiring an additional 44 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of a number of research reports. Royal Bank Of Canada dropped their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $555.50.

Chemed Trading Up 0.0%

Chemed stock opened at $447.92 on Tuesday. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60. The firm’s fifty day simple moving average is $437.01 and its 200-day simple moving average is $441.68. The company has a market capitalization of $6.34 billion, a P/E ratio of 23.69, a P/E/G ratio of 2.18 and a beta of 0.44.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the transaction, the chief executive officer owned 94,197 shares in the company, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 3.29% of the company’s stock.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.